Patent · US Active

Ras inhibitors

US11566007B2 · kind B2 · utility

7Cited by
19References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 4, 2020
Grant dateJan 31, 2023
Priority date—
Expiry dateNov 4, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The disclosure features macrocyclic compounds, and pharmaceutical compositions and protein complexes thereof, capable of inhibiting Ras proteins, and their uses in the treatment of cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.